相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New 4-nitro-imidazole-N-glycinyl-hydrazones Designed as Trypanocidal Analogues of Benznidazole
Giulianna P. de Alcantara et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2023)
Structural Alterations of the Address Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity
Hongguang Ma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation
Haibo Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges?
Marcin Cieslak et al.
PHARMACEUTICS (2023)
The evolution of cannabinoid receptors in cancer
Nakea M. Pennant et al.
WIRES MECHANISMS OF DISEASE (2023)
The Outcomes of Small-Molecule Kinase Inhibitors and the Role of ROCK2 as a Molecular Target for the Treatment of Alzheimer's Disease
Heber Victor Tolomeu et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2022)
Discovery and Optimization of Seven-Membered Lactam-Based Compounds to Phenocopy the Inhibition of the Aurora Kinase B
Jian Huang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
Gisele Barbosa et al.
PHARMACEUTICALS (2022)
Discovery of 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo
Jie Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitors
Chiara Brullo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile
Tingting Jin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas
Bin Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A high-content screen for anti-mitosis and polyploidy-induction identifies an unknown activity of two benzophenanthridine alkaloids from Corydalis longicalcarataz.star;
Jinhua Li et al.
PHYTOCHEMISTRY LETTERS (2021)
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy
Sumanta Garai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases
Kongjun Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Installing the magic methyl - C-H methylation in synthesis
Daniya Aynetdinova et al.
CHEMICAL SOCIETY REVIEWS (2021)
Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells
Kuojun Zhang et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Exploring Methamphetamine Nonenantioselectively Targeting Toll-like Receptor 4/Myeloid Differentiation Protein 2 by in Silico Simulations and Wet-Lab Techniques
Xiaozheng Zhang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies
Isabelle Karine da Costa Nunes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Li-Qiang Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Alexander A. Vinogradov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell
Xiaohui Wang et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Homologation: A Versatile Molecular Modification Strategy to Drug Discovery
Lidia M. Lima et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
The Use of Conformational Restriction in Medicinal Chemistry
Pedro de Sena M. Pinheiro et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease
Claudia Mugnaini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Characterization of 17-CyclopropyInnethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment
Samuel Obeng et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
Daniel A. Rodrigues et al.
PHARMACEUTICALS (2019)
Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping
Wei Tuo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection
Johannes Vermehren et al.
JOURNAL OF HEPATOLOGY (2018)
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria
Robert J. Moreau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting EZH2 with tazemetostat
Shinichi Makita et al.
LANCET ONCOLOGY (2018)
Theoretical and experimental characterization of 1,4-N•••S σ-hole intramolecular interactions in bioactive N-acylhydrazone derivatives
Pedro de Sena Murteira Pinheiro et al.
NEW JOURNAL OF CHEMISTRY (2018)
Orally Active Peptides: Is There a Magic Bullet?
Andreas F. B. Raeder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Synthesis of novel antiproliferative hybrid bis-(3-indolyl)methane phosphonate derivatives
Aitor Maestro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors
Ramon Guerra de Oliveira et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-7-Hydroxy-N-[(1S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)
Pauline W. Ondachi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, Synthesis, Experimental and Theoretical Characterization of a New Multitarget 2-Thienyl-N-Acylhydrazone Derivative
Isadora T. S. Bastos et al.
PHARMACEUTICALS (2018)
Inhibitors of Protein Methyltransferases and Demethylases
H. Umit Kaniskan et al.
CHEMICAL REVIEWS (2018)
Chemical Ligand Space of Cereblon
Iuliia Boichenko et al.
ACS OMEGA (2018)
Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor Antagonists
Chad M. Kormos et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Conformational control in structure-based drug design
Yajun Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Yiqun Zhang et al.
CANCER CELL (2017)
Targeting the endocannabinoid system: future therapeutic strategies
Oier Aizpurua-Olaizola et al.
DRUG DISCOVERY TODAY (2017)
New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors
Natanael D. Segretti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors
Daniel A. Rodrigues et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of Ligand Binding Hot Spots of the Histamine H1 Receptor following Structure-Based Fragment Optimization
Sebastiaan Kuhne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat
Kevin W. Kuntz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Twenty years on: the impact of fragments on drug discovery
Daniel A. Erlanson et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors
Isabelle Karine da Costa Nunes et al.
PLOS ONE (2016)
Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4
Ryan Bachtell et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
Yiwu Yao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery and Optimization of Novel Antagonists to the Human Neurokinin-3 Receptor for the Treatment of Sex-Hormone Disorders (Part I)
Hamid R. Hoveyda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents
Dorothee Bardiot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Applying thermodynamic profiling in lead finding and optimization
Gerhard Klebe
NATURE REVIEWS DRUG DISCOVERY (2015)
Profound Methyl Effects in Drug Discovery and a Call for New C-H Methylation Reactions
Heike Schoenherr et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain
Sean P. Hollinshead et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Development of κ Opioid Receptor Antagonists
F. Ivy Carroll et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor
Carla Moreira Leal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
Xiao-Liang Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Methyl Effects on Protein-Ligand Binding
Cheryl S. Leung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design, Synthesis, and Pharmacological Evaluation of N-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 Inhibitors
Arthur E. Kuemmerle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The Methylation Effect in Medicinal Chemistry
Eliezer J. Barreiro et al.
CHEMICAL REVIEWS (2011)
Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β
Carolina M. Avila et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry
Minoru Ishikawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Optimization of the Potency and Pharmacokinetic Properties of a Macrocyclic Ghrelin Receptor Agonist (Part I): Development of Ulimorelin (TZP-101) from Hit to Clinic
Hamid R. Hoveyda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1 Receptor
Chris de Graaf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Medicinal Chemist's Guide to Molecular Interactions
Caterina Bissantz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives
Arthur E. Kummerle et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas
Ta-Jen Liu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The structure of dimeric ROCK I reveals the mechanism for ligand selectivity
M Jacobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bioisosterism: A useful strategy for molecular modification and drug design
LMA Lima et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Fragment-based lead discovery
DC Rees et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Mitotic kinases as regulators of cell division and its checkpoints
EA Nigg
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
